BSE:532034

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Safal Herbs Limited engages in the trading of herbal products in India.


Snowflake Analysis

Flawless balance sheet with weak fundamentals.

Share Price & News

How has Safal Herbs's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 532034's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0%

532034

5.9%

IN Retail Distributors

6.4%

IN Market


1 Year Return

40.8%

532034

-16.6%

IN Retail Distributors

-16.2%

IN Market

Return vs Industry: 532034 exceeded the Indian Retail Distributors industry which returned -16.6% over the past year.

Return vs Market: 532034 exceeded the Indian Market which returned -16.2% over the past year.


Shareholder returns

532034IndustryMarket
7 Day0%5.9%6.4%
30 Day0%4.5%8.4%
90 Day9.5%-13.9%-8.9%
1 Year40.8%40.8%-15.7%-16.6%-14.6%-16.2%
3 Year-63.6%-63.6%-30.2%-31.5%-4.9%-9.9%
5 Year-96.7%-96.7%-63.0%-63.5%21.6%10.2%

Price Volatility Vs. Market

How volatile is Safal Herbs's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Safal Herbs undervalued compared to its fair value and its price relative to the market?

1.54x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate 532034's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate 532034's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: 532034 is unprofitable, so we can't compare its PE Ratio to the Retail Distributors industry average.

PE vs Market: 532034 is unprofitable, so we can't compare its PE Ratio to the Indian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 532034's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 532034 is overvalued based on its PB Ratio (1.5x) compared to the IN Retail Distributors industry average (0.6x).


Next Steps

Future Growth

How is Safal Herbs forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

2.4%

Forecasted Retail industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Safal Herbs has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Safal Herbs performed over the past 5 years?

-61.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 532034 is currently unprofitable.

Growing Profit Margin: 532034 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 532034 is unprofitable, and losses have increased over the past 5 years at a rate of -61.7% per year.

Accelerating Growth: Unable to compare 532034's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 532034 is unprofitable, making it difficult to compare its past year earnings growth to the Retail Distributors industry (3.8%).


Return on Equity

High ROE: 532034 has a negative Return on Equity (-0.25%), as it is currently unprofitable.


Next Steps

Financial Health

How is Safal Herbs's financial position?


Financial Position Analysis

Short Term Liabilities: 532034's short term assets (₹88.2M) exceed its short term liabilities (₹126.0K).

Long Term Liabilities: 532034 has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: 532034 is debt free.

Reducing Debt: 532034 has no debt compared to 5 years ago when its debt to equity ratio was 154.7%.

Debt Coverage: 532034 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 532034 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Safal Herbs's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 532034's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 532034's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 532034's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 532034's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 532034's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.6yrs

Average board tenure


CEO

Pawan Garg

no data

Tenure

Mr. Pawan Kumar Garg serves as Chief Executive Officer and Managing Director of Safal Herbs Ltd. and has been its Additional Director since May 15, 2018. Mr. Garg is having more than 8 years of experience  ...


Board Members

NamePositionTenureCompensationOwnership
Pawan Garg
CEO, MD & Additional Directorno datano datano data
Sonia Saini
Non Executive Independent Director5.08yrsno datano data
Narender Kumar
Non-Executive Independent Director5.33yrsno datano data
Priya Gautam
Additional Director0.58yrno datano data

3.6yrs

Average Tenure

Experienced Board: 532034's board of directors are considered experienced (3.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Safal Herbs Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Safal Herbs Limited
  • Ticker: 532034
  • Exchange: BSE
  • Founded: 1994
  • Industry: Distributors
  • Sector: Retail
  • Market Cap: ₹138.000m
  • Shares outstanding: 100.00m
  • Website: https://www.safalherbs.com

Location

  • Safal Herbs Limited
  • A-66, Guru Nanak Pura
  • 2nd Floor
  • New Delhi
  • Delhi
  • 110092
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
532034BSE (Mumbai Stock Exchange)YesEquity SharesININRJan 2012

Biography

Safal Herbs Limited engages in the trading of herbal products in India. The company was formerly known as Parikh Herbals Limited and changed its name to Safal Herbs Limited in July 2012. Safal Herbs Limited was incorporated in 1994 and is based in New Delhi, India. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/06/05 06:33
End of Day Share Price2020/03/11 00:00
Earnings2019/12/31
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.